LIPID ABNORMALITIES, LIPOPROTEIN AND APOPROTEIN PATTERN IN NON-DIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE

The present study was carried out to explore the altered lipid, lipoprotein and apoprotein abnormalities along with lipoprotein (a) in chronic kidney disease patients with stage I to V which were further divided into group 1 (stage I and II), group 2 (stage III and IV) and group 3 (stage V). 50 chro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of clinical biochemistry 2022-05, Vol.25 (1), p.47
Hauptverfasser: Rao, A.M, Bitla, A.R, Reddy, E.P, Sivakumar, V, Rao, P.V.L.N.Srinivasa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 47
container_title Indian journal of clinical biochemistry
container_volume 25
creator Rao, A.M
Bitla, A.R
Reddy, E.P
Sivakumar, V
Rao, P.V.L.N.Srinivasa
description The present study was carried out to explore the altered lipid, lipoprotein and apoprotein abnormalities along with lipoprotein (a) in chronic kidney disease patients with stage I to V which were further divided into group 1 (stage I and II), group 2 (stage III and IV) and group 3 (stage V). 50 chronic kidney disease patients with stage I to V and 20 healthy normal subjects as controls were recruited for this study. Among the various parameters tested triglyceride levels were high in group 1 and 2, whereas VLDL cholesterol, Lp (a) and apo B levels were significantly high in all the groups when compared to controls (P
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A734897317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A734897317</galeid><sourcerecordid>A734897317</sourcerecordid><originalsourceid>FETCH-LOGICAL-g677-7b4cc049b37cba5e5e03f149523bbd64ca03b10e3b842f478d21e9b5e98efacd3</originalsourceid><addsrcrecordid>eNptjEFLxDAQhXtQcF39DwGvVpIm3TTH2EYbrElpA7JeliRNl0p3F6z_HyMKepA5zHvfvDdnyQoyClPEUH6RXC7LG4SYQIJWydzIVlaA3yvdPfNGGin6WxChbjtthFSAq3j-tS03RnQKRKm0SivJm-2rqL64FMr04EWaGpR1p5UswZOslNiCSvaC9-IqOR_tvITrn71OzIMwZZ02-lGWvEn3G0pT6oj3kDCHqXc2D3mAeESE5Rl2btgQbyF2CAbsCpKNhBZDhgJzeWBFGK0f8Dq5-X67t3PYTcfx9PFu_WFa_I5TTApGMaIxdfdPKs4QDpM_HcM4Rf6n8AkT6Vn3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>LIPID ABNORMALITIES, LIPOPROTEIN AND APOPROTEIN PATTERN IN NON-DIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Rao, A.M ; Bitla, A.R ; Reddy, E.P ; Sivakumar, V ; Rao, P.V.L.N.Srinivasa</creator><creatorcontrib>Rao, A.M ; Bitla, A.R ; Reddy, E.P ; Sivakumar, V ; Rao, P.V.L.N.Srinivasa</creatorcontrib><description>The present study was carried out to explore the altered lipid, lipoprotein and apoprotein abnormalities along with lipoprotein (a) in chronic kidney disease patients with stage I to V which were further divided into group 1 (stage I and II), group 2 (stage III and IV) and group 3 (stage V). 50 chronic kidney disease patients with stage I to V and 20 healthy normal subjects as controls were recruited for this study. Among the various parameters tested triglyceride levels were high in group 1 and 2, whereas VLDL cholesterol, Lp (a) and apo B levels were significantly high in all the groups when compared to controls (P&lt;0.05). However, LDL cholesterol level was significantly low in group 3 only as compared to control group (P&lt;0.05). Apoprotein AI values also showed significant decrease in all groups as compared to controls (P&lt;0.05). Though total cholesterol levels in group 1 and LDL levels in group 1 and 2 were higher than controls, but the values attained not statistically significant (P&gt;0.05). In conclusion high levels of VLDL cholesterol, Lp (a), apo B and low levels of apoprotein AI as reported in this study are the major lipid disorders in the development of cardiovascular complications at all the stages in these patients. KEY WORDS Chronic Kidney Disease, End stage renal disease, Lipid Profile, Lp(a), Lipoprotein Metabolism.</description><identifier>ISSN: 0970-1915</identifier><language>eng</language><publisher>Springer</publisher><subject>Blood cholesterol ; Chronic kidney failure ; Development and progression ; Lipoprotein A ; Low density lipoproteins ; Medical research ; Medicine, Experimental ; Physiological aspects ; Trans fatty acids ; Triglycerides</subject><ispartof>Indian journal of clinical biochemistry, 2022-05, Vol.25 (1), p.47</ispartof><rights>COPYRIGHT 2022 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Rao, A.M</creatorcontrib><creatorcontrib>Bitla, A.R</creatorcontrib><creatorcontrib>Reddy, E.P</creatorcontrib><creatorcontrib>Sivakumar, V</creatorcontrib><creatorcontrib>Rao, P.V.L.N.Srinivasa</creatorcontrib><title>LIPID ABNORMALITIES, LIPOPROTEIN AND APOPROTEIN PATTERN IN NON-DIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE</title><title>Indian journal of clinical biochemistry</title><description>The present study was carried out to explore the altered lipid, lipoprotein and apoprotein abnormalities along with lipoprotein (a) in chronic kidney disease patients with stage I to V which were further divided into group 1 (stage I and II), group 2 (stage III and IV) and group 3 (stage V). 50 chronic kidney disease patients with stage I to V and 20 healthy normal subjects as controls were recruited for this study. Among the various parameters tested triglyceride levels were high in group 1 and 2, whereas VLDL cholesterol, Lp (a) and apo B levels were significantly high in all the groups when compared to controls (P&lt;0.05). However, LDL cholesterol level was significantly low in group 3 only as compared to control group (P&lt;0.05). Apoprotein AI values also showed significant decrease in all groups as compared to controls (P&lt;0.05). Though total cholesterol levels in group 1 and LDL levels in group 1 and 2 were higher than controls, but the values attained not statistically significant (P&gt;0.05). In conclusion high levels of VLDL cholesterol, Lp (a), apo B and low levels of apoprotein AI as reported in this study are the major lipid disorders in the development of cardiovascular complications at all the stages in these patients. KEY WORDS Chronic Kidney Disease, End stage renal disease, Lipid Profile, Lp(a), Lipoprotein Metabolism.</description><subject>Blood cholesterol</subject><subject>Chronic kidney failure</subject><subject>Development and progression</subject><subject>Lipoprotein A</subject><subject>Low density lipoproteins</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Physiological aspects</subject><subject>Trans fatty acids</subject><subject>Triglycerides</subject><issn>0970-1915</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjEFLxDAQhXtQcF39DwGvVpIm3TTH2EYbrElpA7JeliRNl0p3F6z_HyMKepA5zHvfvDdnyQoyClPEUH6RXC7LG4SYQIJWydzIVlaA3yvdPfNGGin6WxChbjtthFSAq3j-tS03RnQKRKm0SivJm-2rqL64FMr04EWaGpR1p5UswZOslNiCSvaC9-IqOR_tvITrn71OzIMwZZ02-lGWvEn3G0pT6oj3kDCHqXc2D3mAeESE5Rl2btgQbyF2CAbsCpKNhBZDhgJzeWBFGK0f8Dq5-X67t3PYTcfx9PFu_WFa_I5TTApGMaIxdfdPKs4QDpM_HcM4Rf6n8AkT6Vn3</recordid><startdate>20220524</startdate><enddate>20220524</enddate><creator>Rao, A.M</creator><creator>Bitla, A.R</creator><creator>Reddy, E.P</creator><creator>Sivakumar, V</creator><creator>Rao, P.V.L.N.Srinivasa</creator><general>Springer</general><scope/></search><sort><creationdate>20220524</creationdate><title>LIPID ABNORMALITIES, LIPOPROTEIN AND APOPROTEIN PATTERN IN NON-DIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE</title><author>Rao, A.M ; Bitla, A.R ; Reddy, E.P ; Sivakumar, V ; Rao, P.V.L.N.Srinivasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g677-7b4cc049b37cba5e5e03f149523bbd64ca03b10e3b842f478d21e9b5e98efacd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood cholesterol</topic><topic>Chronic kidney failure</topic><topic>Development and progression</topic><topic>Lipoprotein A</topic><topic>Low density lipoproteins</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Physiological aspects</topic><topic>Trans fatty acids</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rao, A.M</creatorcontrib><creatorcontrib>Bitla, A.R</creatorcontrib><creatorcontrib>Reddy, E.P</creatorcontrib><creatorcontrib>Sivakumar, V</creatorcontrib><creatorcontrib>Rao, P.V.L.N.Srinivasa</creatorcontrib><jtitle>Indian journal of clinical biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rao, A.M</au><au>Bitla, A.R</au><au>Reddy, E.P</au><au>Sivakumar, V</au><au>Rao, P.V.L.N.Srinivasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LIPID ABNORMALITIES, LIPOPROTEIN AND APOPROTEIN PATTERN IN NON-DIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE</atitle><jtitle>Indian journal of clinical biochemistry</jtitle><date>2022-05-24</date><risdate>2022</risdate><volume>25</volume><issue>1</issue><spage>47</spage><pages>47-</pages><issn>0970-1915</issn><abstract>The present study was carried out to explore the altered lipid, lipoprotein and apoprotein abnormalities along with lipoprotein (a) in chronic kidney disease patients with stage I to V which were further divided into group 1 (stage I and II), group 2 (stage III and IV) and group 3 (stage V). 50 chronic kidney disease patients with stage I to V and 20 healthy normal subjects as controls were recruited for this study. Among the various parameters tested triglyceride levels were high in group 1 and 2, whereas VLDL cholesterol, Lp (a) and apo B levels were significantly high in all the groups when compared to controls (P&lt;0.05). However, LDL cholesterol level was significantly low in group 3 only as compared to control group (P&lt;0.05). Apoprotein AI values also showed significant decrease in all groups as compared to controls (P&lt;0.05). Though total cholesterol levels in group 1 and LDL levels in group 1 and 2 were higher than controls, but the values attained not statistically significant (P&gt;0.05). In conclusion high levels of VLDL cholesterol, Lp (a), apo B and low levels of apoprotein AI as reported in this study are the major lipid disorders in the development of cardiovascular complications at all the stages in these patients. KEY WORDS Chronic Kidney Disease, End stage renal disease, Lipid Profile, Lp(a), Lipoprotein Metabolism.</abstract><pub>Springer</pub></addata></record>
fulltext fulltext
identifier ISSN: 0970-1915
ispartof Indian journal of clinical biochemistry, 2022-05, Vol.25 (1), p.47
issn 0970-1915
language eng
recordid cdi_gale_infotracmisc_A734897317
source EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Blood cholesterol
Chronic kidney failure
Development and progression
Lipoprotein A
Low density lipoproteins
Medical research
Medicine, Experimental
Physiological aspects
Trans fatty acids
Triglycerides
title LIPID ABNORMALITIES, LIPOPROTEIN AND APOPROTEIN PATTERN IN NON-DIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A29%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LIPID%20ABNORMALITIES,%20LIPOPROTEIN%20AND%20APOPROTEIN%20PATTERN%20IN%20NON-DIALYZED%20PATIENTS%20WITH%20CHRONIC%20KIDNEY%20DISEASE&rft.jtitle=Indian%20journal%20of%20clinical%20biochemistry&rft.au=Rao,%20A.M&rft.date=2022-05-24&rft.volume=25&rft.issue=1&rft.spage=47&rft.pages=47-&rft.issn=0970-1915&rft_id=info:doi/&rft_dat=%3Cgale%3EA734897317%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A734897317&rfr_iscdi=true